✦ LIBER ✦

Clinical and pharmaceutical management of a high-risk diabetic population undergoing percutaneous coronary interventions

✍ Scribed by S Delcrè; M Anselmino; C Moretti; G Biondi-Zoccai; A Abbate; I Sheiban

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Occurrence and clinical significance of

✍ Scott D. Berkowitz; David C. Sane; Kristina N. Sigmon; Jane H. Shavender; Robert 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Clinical outcome of “high-risk” vs “elec

✍ James J. Ferguson; Timothy J. McDonough; Seth J. Worley; William J. French; John 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Development and validation of a bleeding

✍ Gilles Montalescot; Genevieve Salette; Gabriel Steg; Marc Cohen; Harvey D. White 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Downstream administration of a high-dose

✍ Gian B. Danzi; Marco Sesana; Cinzia Capuano; Luigi Mauri; Simonetta Predolini; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Comparison of Risks and Clinical Predict

✍ ERIC CHONG; KIAN K. POH; SHEN LIANG; CHAO Y. SOON; HUAY-CHEEM TAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

The impact of diabetes on clinical and e

✍ Ameet Bakhai; Mary Ann Clark; Mike Lacey; Elise Pelletier; David J. Cohen; Beth 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB